In the present study, aortic HO-1 mRNA and protein expressions in response to prescription of lipid-lowering and antihypertensive therapies as well as therapeutic anticoagulation were analyzed in aortic tissues of patients with late-stage AAA. Here, HMOX1 is linked to triple-A syndrome.